Riskpilot← Back to searchSign inGet full accessFace & Nose AB
ABActiveOrg 5568503881Flottiljgatan 67Medical specialists activities · NACE 8622Est. 20110 employees
Revenue 2024
SEK 99K
-92% vs 2023
EBITDA margin
-27.5%
-104% vs 2023
Equity ratio
34.7%
Financial strength
Net profit 2024
SEK -25K
-104% vs 2023
| Revenue | SEK 99K | -92% |
| EBITDA | SEK -27K | -104% |
| Net profit | SEK -25K | -104% |
| Total assets | SEK 388K | -60% |
| Equity | SEK 135K | -78% |
| Employees | 0 | — |
Legal name
Face & Nose AB
Org number
5568503881
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
21 april 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultation och uppdrag inom medicin och kirurgi.
Address
Flottiljgatan 67
Phone
+46214755250
Email
shemal.c@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 857 | 345 | 1 333 | 1 228 | 99 |
| Staff expenses | — | — | — | −17 | 19 |
| EBITDA | 97 | 172 | 925 | 696 | −27 |
| Depreciation & amort. | −2 | −2 | −2 | −2 | — |
| EBIT | 95 | 170 | 923 | 694 | −27 |
| Net financials | −4 | −2 | −1 | 10 | 3 |
| Profit before tax | 91 | 167 | 922 | 704 | −25 |
| Tax | 80 | −66 | −190 | −145 | — |
| Net profit | 171 | 101 | 732 | 559 | −25 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 525 | 527 | 1 181 | 973 | 388 |
| Equity | 433 | 385 | 783 | 609 | 135 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 91 | 142 | 398 | 364 | 253 |
| Total debt | 91 | 142 | 398 | 364 | 253 |
EBITDA margin
-27.5%
This company
15.8%
Market median
-274% vs market
20202024
Equity ratio
34.7%
This company
38.2%
Market median
+9% vs market
20202024
Return on equity
-18.2%
This company
18.4%
Market median
-199% vs market
20202024
Net profit margin
-24.7%
This company
8.1%
Market median
-405% vs market
20202024
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
20202024
Debt / equity
1.88×
This company
0.62×
Market median
-203% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Face & Nose AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Delnia Razzazi | Deputy Board Member | 0 companies |
| Per-David Samuelson | Deputy Board Member | 0 companies |
| Shemal Celiker | Board of Directors | 0 companies |